Meal-Exercise Challenge and Physical Activity Reduction Impact on Immunity and Inflammation (MERIIT)

April 28, 2015 updated by: Universidade do Porto

In a society where exercise is prescribed by physicians to increase physical condition, improve dietary habits and reduce cardiovascular risk, the impact of exercise, acute or chronic, and diet in inflammation and immunity is unknown. Specific populations can have different responses towards acute and chronic exercise. Moreover specific conditions, like the type of meal ingested, can interfere with these responses. The true effect of pre-competitive meal exercise in the immunity and inflammatory response is unknown. Acute physical inactivity periods, commonly happens during daily life, related to work or acute illness. New evidence points out that it induces immediate metabolic and endocrinological changes, these can might also be associated with changes in immune response.

Aims of this project are:

  1. to assess the effect of the precompetitive meal on the inflammatory, neuro-immune and metabolic response to exercise;
  2. to assess the effects of sedentary behaviour on inflammatory, neuro-immune and metabolic response;
  3. to assess differences in changes between healthy, asthmatic and obese subjects

Study Overview

Status

Completed

Conditions

Detailed Description

Two interventions will be performed for assessing the research questions and aims:

A) Randomized cross-over, with a wash out period of 7 days, single-blinded trial where two different pre-competitive meals will be followed by an exercise challenge; inflammatory neuro-immune and metabolic response will be assessed before and after each challenge.

Participants will be recruited from advertisement and four different groups will be compared: obese-asthmatic; asthmatic non-obese; obese without asthma and non-asthmatic and non-obese. All patients will be allocated to a meal challenge in which a high fat poor micronutrient meal followed by a Mediterranean meal or vice-versa; meal challenge order will be randomized and participants will be blinded to the intervention. The main outcome for this intervention will be airway inflammation and lung function. All outcomes will be assessed before and 3h after each meal.

A group of individuals will, in the three hours after the meal, perform an exercise challenge, which is aimed to induce acute immune changes.

B) Randomized controlled trial where participants, after a run-in period and eligibility evaluation, will be allocated to an intervention consisting in a reduction of physical activity by 50% or maintaining habitual physical activity for two weeks; inflammatory neuro-immune and metabolic response will be assessed before and after intervention.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Porto, Portugal, 4200
        • Faculty of Nutrition and Food Sciences of the University of Porto
      • Porto, Portugal, 4200
        • Faculty of Sports of Porto University
    • Porto
      • Portugal, Porto, Portugal, 4200
        • Faculty of Medicine of Porto University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • controlled mild to moderate asthma;
  • Body mass index (BMI) ≥ 25 kg/m2; healthy participants (non asthmatic with a BMI 18,5 to 25 kg/m2) will be used for comparison;

Exclusion Criteria:

  • respiratory disease other than asthma;
  • severe asthma according to Global Initiative for Asthma (GINA) guidelines
  • occurrence in previous 4 weeks of screening of upper/lower respiratory tract infection;
  • smoking in the past 6 months and requiring mechanical ventilation for respiratory event within 6 months of screening.
  • Medical conditions (hematologic, cardiovascular, renal, hepatic, neurologic or metabolic) or medication that may interfere with meal or physical activity intervention;
  • Significant chronic infectious diseases (eg, HIV, hepatitis B or C);
  • Abnormal electrocardiogram screening, cardiac arrhythmia, angina, congestive heart failure; renal or hepatic failure and systemic disease, mal-absorption disease history or intestinal inflammatory disease;
  • Women breast-feeding, pregnant or intending pregnancy during study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Meal Exercise Challenge- Order 2
Two different meals,an high fat micronutrient poor meal and Mediterranean Meal will be followed by an exercise challenge and performed at different orders accordingly to the cross over design.
The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an high fat poor micronutrient meal.
The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an Mediterranean meal
Experimental: Meal Exercise Challenge- Order 1

Two different meals,an high fat micronutrient poor meal and Mediterranean Meal will be followed by an exercise challenge and performed at different orders accordingly to the cross over design.

Each arm corresponds to a different intervention order.

The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an high fat poor micronutrient meal.
The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an Mediterranean meal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Airway inflammation
Time Frame: Up to 6 months
  1. Lung function before and after challenge and bronchodilator response;
  2. Exhaled nitric oxide;
  3. Exhaled breath condensate (EBC);
Up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Autonomic nervous system response
Time Frame: Up to 6 months
Rest heart rate; pupillary response, before and after challenge Neuropeptides measurement
Up to 6 months
Oxidative stress biomarkers
Time Frame: Up to 6 months
Assessment of plasma F2-isoprostanes, lipid hydroperoxides, protein carbonyls, hydrogen peroxide and lipid soluble antioxidants
Up to 6 months
Circulating blood leukocyte-total and differential leukocyte counts and lymphocyte subpopulations assessment.
Time Frame: Up to 6 months
Evaluated by flow cytometry: T cell (CD4+/CD8+), and their subsets; B cells (CD19+), Natural Killer (NK) cells (CD16+/56+), their subsets; monocytes subsets; oxidative burst activity
Up to 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histamine skin test reactivity
Time Frame: Up to 6 months
Histamine skin test reactivity, assessed by skin prick test response
Up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Diana Silva, MD, Faculty of Medicine of Porto University
  • Principal Investigator: Rita Moreira, Faculty of Nutrition and Food Sciences of the University of Porto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

December 19, 2013

First Submitted That Met QC Criteria

January 2, 2014

First Posted (Estimate)

January 6, 2014

Study Record Updates

Last Update Posted (Estimate)

April 29, 2015

Last Update Submitted That Met QC Criteria

April 28, 2015

Last Verified

November 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on High fat poor micronutrient meal

3
Subscribe